Harmony Biosciences to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026 | HRMY Stock News
I'm PortAI, I can summarize articles.
Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) will report its fourth quarter and full year 2025 financial results on February 24, 2026, before U.S. markets open. A conference call and webcast will follow at 8:30 a.m. ET to discuss the results. Participants can join by calling 800-274-7083 (domestic) or 203-518-9786 (international) with passcode HRMYQ425. Harmony Biosciences focuses on developing therapies for rare neurological diseases.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: StockTitan The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments